{
  "6638291_syn_1": "Indication: Staging RLL Adenocarcinoma.\nProcedure: EBUS-TBNA.\nSurvey: 2R, 4R, 4L, 7, 10R, 11R.\nSampled: 7 (Pos), 4R (Atypical), 4L (Benign), 10R, 11R.\nDx: N2 positive (Station 7). Stage IIIA.\nPlan: Onc consult.",
  "6638291_syn_2": "PROCEDURE NOTE: [REDACTED] EBUS staging for T2aN0M0 RLL adenocarcinoma. Assessment of the mediastinum revealed an enlarged subcarinal node (Station 7). TBNA of Station 7 yielded adenocarcinoma on ROSE, confirming N2 disease. Contralateral station 4L was negative. The patient is upstaged to IIIA.",
  "6638291_syn_3": "CPT 31653: EBUS sampling of 3+ stations.\nStations sampled: 7, 4R, 4L, 10R, 11R.\nResults:\n- 7: Positive (Adeno).\n- 4R: Atypical.\n- Others: Negative/Reactive.\nClinical Impact: Confirmation of N2 disease significantly alters management (multimodal therapy vs surgery first).",
  "6638291_syn_4": "Procedure: EBUS\nPatient: [REDACTED], 55F\nIndication: Staging lung cancer.\nSteps:\n1. US check of nodes.\n2. Needles into 7, 4R, 4L, 10R, 11R.\n3. ROSE said Station 7 is cancer.\n4. That means N2 disease.\nPlan: Chemo/Rad referral?",
  "6638291_syn_5": "Barbara Perry here for staging ebus. she has a cancer in the right lower lobe. checked the middle nodes station 7 was big. poked it and it is cancer. poked the other ones 4r 4l 10r 11r mostly benign. so she has n2 disease now. needs oncology.",
  "6638291_syn_6": "EBUS-TBNA Staging. Patient: Elizabeth Powell. Primary: RLL Adeno. Stations Sampled: 7 (Pos), 4R, 4L, 10R, 11R. Findings: N2 disease confirmed at Station 7 (28mm). Complications: None.",
  "6638291_syn_7": "[Indication] Staging RLL Adenocarcinoma.\n[Anesthesia] Moderate.\n[Description] EBUS-TBNA stations 7, 4R, 4L, 10R, 11R. Station 7 positive for malignancy.\n[Plan] Oncology consult for Stage IIIA.",
  "6638291_syn_8": "[REDACTED] in for staging of her lung cancer. We used the EBUS scope to sample lymph nodes in the center of her chest. Unfortunately, the lymph node under the main airway (Station 7) tested positive for cancer cells. This changes her stage to IIIA. We sampled other nodes to be thorough, but they were negative. We will discuss the next steps with oncology.",
  "6638291_syn_9": "Operation: EBUS mediastinal staging.\nSubject: [REDACTED].\nOutcome: Transbronchial aspiration of the subcarinal node (St 7) demonstrated adenocarcinoma. This confirms mediastinal nodal involvement (N2). Other stations were sampled for completeness.",
  "6638291": "PT: [REDACTED] || MRN: [REDACTED] || Date: [REDACTED]\nAttending: Harrison, Robert MD || Fellow: None this case\nPROCEDURE: EBUS with TBNA for mediastinal staging\nHISTORY: 55yo F with RLL adenocarcinoma, clinically T2aN0M0, undergoing invasive staging\nSEDATION PROTOCOL:\n•\tMidazolam 3mg IV push\n•\tFentanyl 75mcg IV push\n•\tLidocaine 2% topical 15mL via bronchoscope\n•\tPropofol infusion PRN (total 180mg used)\nEBUS SURVEY: Bronchoscope advanced without difficulty. Mediastinal ultrasound performed.\n2R: 10mm (normal, not sampled) 4R: 19mm (oval, sampled) 4L: 15mm (normal hilum, sampled for completeness) 7: 28mm (enlarged, hypoechoic, sampled)\n10R: 12mm (sampled) 11R: 16mm (sampled)\nASPIRATION RESULTS:\nStation 7: 28x16mm\n•\t4 passes with 22-gauge needle\n•\tROSE by Dr. Chen (pathology): POSITIVE for adenocarcinoma\n•\tElastography: firm consistency\nStation 4R: 19x12mm\n•\t3 passes\n•\tROSE: Atypical cells present\nStation 4L: 15x9mm\n•\t2 passes\n•\tROSE: Benign\nStation 10R: 12x8mm\n•\t2 passes\n•\tROSE: Reactive lymphocytes\nStation 11R: 16x10mm\n•\t2 passes\n•\tROSE: Benign\nCOMPLICATIONS: None BLOOD LOSS: Minimal (<5cc) TOLERANCE: Good\nINTERPRETATION: N2 disease confirmed via ROSE cytology at Station 7. Patient upstaged to at least Stage IIIA. Final pathology pending.\nPLAN:\n•\tMedical oncology consult\n•\tMultidisciplinary tumor board\n•\tPatient counseled on findings\n/s/ Robert Harrison MD Interventional Pulmonology [REDACTED] 1522hrs\n________________________________________\n\nRIVERSIDE HOSPITAL SYSTEM Procedure Documentation"
}
